These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
84 related articles for article (PubMed ID: 22868239)
1. Long-term follow-up and pattern of failure for T1-T2 glottic cancer after definitive radiation therapy. Mourad WF; Hu KS; Shourbaji RA; Woode R; Harrison LB Am J Clin Oncol; 2013 Dec; 36(6):580-3. PubMed ID: 22868239 [TBL] [Abstract][Full Text] [Related]
2. Decreased local control following radiation therapy alone in early-stage glottic carcinoma with anterior commissure extension. Zouhair A; Azria D; Coucke P; Matzinger O; Bron L; Moeckli R; Do HP; Mirimanoff RO; Ozsahin M Strahlenther Onkol; 2004 Feb; 180(2):84-90. PubMed ID: 14762660 [TBL] [Abstract][Full Text] [Related]
3. The impact of computed tomography on early glottic cancer outcomes. Mourad WF; Hu KS; Shourbaji RA; Ishihara D; Lin W; Kumar M; Blakaj DM; Harrison LB Onkologie; 2013; 36(3):83-6. PubMed ID: 23485994 [TBL] [Abstract][Full Text] [Related]
4. Hyperfractionated accelerated radiotherapy for T1,2 glottic carcinoma. Consideration of time-dose factors. Sakata K; Someya M; Hori M; Nakata K; Takagi M; Hareyama M Strahlenther Onkol; 2008 Jul; 184(7):364-9. PubMed ID: 19016035 [TBL] [Abstract][Full Text] [Related]
5. Comparison of early glottic and supraglottic carcinoma treated with conventional fractionation of radiotherapy. Inoue T; Inoue T; Ikeda H; Teshima T; Yamazaki H; Murayama S; Othani M; Ozeki S Strahlenther Onkol; 1993 Oct; 169(10):584-9. PubMed ID: 8235982 [TBL] [Abstract][Full Text] [Related]
6. Comprehensive head and neck radiotherapy dose-volume constraints do not apply to smaller volumes. Mourad WF; Shasha D; Blakaj DM; Khorsandi AS; Shourbaji RA; Glanzman J; Kabarriti R; Young R; Patel S; Katsoulakis E; Gámez M; Woode R; Lazarus C; Concert C; Hu KS; Harrison LB Anticancer Res; 2013 Oct; 33(10):4483-9. PubMed ID: 24123019 [TBL] [Abstract][Full Text] [Related]
7. Hypofractionated radiotherapy for T1N0M0 glottic cancer: retrospective analysis of two different cohorts of dose-fractionation schedules from a single institution. Laskar SG; Baijal G; Murthy V; Chilukuri S; Budrukkar A; Gupta T; Agarwal JP Clin Oncol (R Coll Radiol); 2012 Dec; 24(10):e180-6. PubMed ID: 22862908 [TBL] [Abstract][Full Text] [Related]
8. Conservative treatment of early glottic carcinomas with exclusive radiotherapy. Thariat J; Bruchon Y; Bonnetain F; Barillot I; Truc G; Peignaux K; Horiot JC; Maingon P Cancer Radiother; 2004 Oct; 8(5):288-96. PubMed ID: 15561594 [TBL] [Abstract][Full Text] [Related]
9. Radiotherapy for T1 and T2 laryngeal cancer: the Dalhousie University experience. Hafidh M; Tibbo J; Trites J; Corsten G; Hart RD; Nasser J; Wilke D; Mark Taylor S J Otolaryngol Head Neck Surg; 2009 Aug; 38(4):434-9. PubMed ID: 19755083 [TBL] [Abstract][Full Text] [Related]
10. Radiotherapy for patients with early-stage glottic carcinoma: univariate and multivariate analyses in a group of consecutive, unselected patients. Franchin G; Minatel E; Gobitti C; Talamini R; Vaccher E; Sartor G; Politi D; Trovò MG; Barzan L Cancer; 2003 Aug; 98(4):765-72. PubMed ID: 12910521 [TBL] [Abstract][Full Text] [Related]
11. Radiotherapy with 6-megavolt photons for early glottic carcinoma: potential impact of extension to the posterior vocal cord. Lee JH; Machtay M; McKenna MG; Weinstein GS; Markiewicz DA; Krisch RE; Kligerman MM Am J Otolaryngol; 2001; 22(1):43-54. PubMed ID: 11172214 [TBL] [Abstract][Full Text] [Related]
12. Patterns of failure for early-stage glottic carcinoma: 10 years' experience in conformal radiotherapy era. Sert F; Kaya I; Ozturk K; Esassolak M J Cancer Res Ther; 2019; 15(3):576-581. PubMed ID: 31169223 [TBL] [Abstract][Full Text] [Related]
14. Carbon dioxide laser salvage surgery after radiotherapy failure in T1 and T2 glottic carcinoma. Puxeddu R; Piazza C; Mensi MC; Ledda GP; Argiolas F; Peretti G Otolaryngol Head Neck Surg; 2004 Jan; 130(1):84-8. PubMed ID: 14726915 [TBL] [Abstract][Full Text] [Related]
15. Radiation therapy for management of t1-t2 glottic cancer at a private practice. Jones DA; Mendenhall CM; Kirwan J; Morris CG; Donnan A; Holwerda S; Kraus ST; Mann CJ; Grant JR; Donnan B; Mendenhall WM Am J Clin Oncol; 2010 Dec; 33(6):587-90. PubMed ID: 20051812 [TBL] [Abstract][Full Text] [Related]
16. Radiation therapy for early stage (T1-T2) sarcomatoid carcinoma of true vocal cords: outcomes and patterns of failure. Ballo MT; Garden AS; El-Naggar AK; Gillenwater AM; Morrison WH; Goepfert H; Ang KK Laryngoscope; 1998 May; 108(5):760-3. PubMed ID: 9591559 [TBL] [Abstract][Full Text] [Related]
17. Significance of pretreatment hemoglobin level in patients with T1 glottic cancer. Canaday DJ; Regine WF; Mohiuddin M; Zollinger W; Machtay M; Lee J; Schultz D; Rudoltz MS Radiat Oncol Investig; 1999; 7(1):42-8. PubMed ID: 10030623 [TBL] [Abstract][Full Text] [Related]
18. Factors leading to the use of alternate treatment modalities following transoral laser excision of T1 and T2 glottic squamous cell carcinoma. Pham TA; De Freitas R; Sigston E; Vallance N ANZ J Surg; 2012 Oct; 82(10):720-3. PubMed ID: 22901105 [TBL] [Abstract][Full Text] [Related]
19. High daily fraction dose external radiotherapy for T1 glottic carcinoma: treatment results and prognostic factors. Gultekin M; Ozyar E; Cengiz M; Ozyigit G; Hayran M; Hosal S; Akyol F Head Neck; 2012 Jul; 34(7):1009-14. PubMed ID: 22052787 [TBL] [Abstract][Full Text] [Related]
20. Role of radiotherapy in early glottic carcinoma. Smee RI; Meagher NS; Williams JR; Broadley K; Bridger GP Head Neck; 2010 Jul; 32(7):850-9. PubMed ID: 20029987 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]